Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

LSZ-102 is an estrogen receptor α (ERα) degrader (IC50 = 0.2 nM).1 It reduces 17β-estradiol-induced transcription in a reporter assay using MCF-7 breast cancer cells expressing ERα (IC50 = 6 nM). LSZ-102 decreases the proliferation of MCF-7 cells (IC50 = 1.7 nM). In vivo, LSZ-102 (20 mg/kg per day) reduces tumor volume in an MCF-7 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Discovery of LSZ102, a potent, orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive breast cancer. J. Med. Chem. 61(7), 2837-2864 (2018).